Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 548

1.

Pharmacological characterization of a simple behavioral response mediated selectively by central adenosine A1 receptors, using in vivo and in vitro techniques.

Marston HM, Finlayson K, Maemoto T, Olverman HJ, Akahane A, Sharkey J, Butcher SP.

J Pharmacol Exp Ther. 1998 Jun;285(3):1023-30.

2.

Pyrazolopyridine derivatives act as competitive antagonists of brain adenosine A1 receptors: [35S]GTPgammaS binding studies.

Ito H, Maemoto T, Akahane A, Butcher SP, Olverman HJ, Finlayson K.

Eur J Pharmacol. 1999 Jan 22;365(2-3):309-15.

PMID:
9988116
3.

Species differences in brain adenosine A1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists.

Maemoto T, Finlayson K, Olverman HJ, Akahane A, Horton RW, Butcher SP.

Br J Pharmacol. 1997 Nov;122(6):1202-8.

4.

Adenosine receptors involved in modulation of noradrenaline release in isolated rat tail artery.

Diniz C, Fresco P, Leal S, Gonçalves J.

Eur J Pharmacol. 2004 Nov 3;504(1-2):17-25.

PMID:
15507216
5.

Characterization of the adenosine receptors mediating hypothermia in the conscious mouse.

Anderson R, Sheehan MJ, Strong P.

Br J Pharmacol. 1994 Dec;113(4):1386-90.

6.
7.
8.

Effects of adenosine receptor agonists and antagonists on audiogenic seizure-sensible DBA/2 mice.

De Sarro G, De Sarro A, Di Paola ED, Bertorelli R.

Eur J Pharmacol. 1999 Apr 29;371(2-3):137-45.

PMID:
10357250
9.
10.

Involvement of adenosine A2A receptor in sleep promotion.

Satoh S, Matsumura H, Hayaishi O.

Eur J Pharmacol. 1998 Jun 19;351(2):155-62.

PMID:
9686998
12.

Interaction of angiotensin II and adenosine A1 and A2A receptor ligands on the writhing test in mice.

Pechlivanova DM, Georgiev VP.

Pharmacol Biochem Behav. 2002 May;72(1-2):23-8.

PMID:
11900765
13.
14.
15.

Binding of [3H]KF17837S, a selective adenosine A2 receptor antagonist, to rat brain membranes.

Nonaka H, Mori A, Ichimura M, Shindou T, Yanagawa K, Shimada J, Kase H.

Mol Pharmacol. 1994 Nov;46(5):817-22.

PMID:
7969067
16.

Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells.

Klotz KN, Hessling J, Hegler J, Owman C, Kull B, Fredholm BB, Lohse MJ.

Naunyn Schmiedebergs Arch Pharmacol. 1998 Jan;357(1):1-9.

PMID:
9459566
17.

Pharmacological characterization of FR194921, a new potent, selective, and orally active antagonist for central adenosine A1 receptors.

Maemoto T, Tada M, Mihara T, Ueyama N, Matsuoka H, Harada K, Yamaji T, Shirakawa K, Kuroda S, Akahane A, Iwashita A, Matsuoka N, Mutoh S.

J Pharmacol Sci. 2004 Sep;96(1):42-52. Epub 2004 Sep 4.

19.

Effects of the new A2 adenosine receptor antagonist 8FB-PTP, an 8 substituted pyrazolo-triazolo-pyrimidine, on in vitro functional models.

Dionisotti S, Conti A, Sandoli D, Zocchi C, Gatta F, Ongini E.

Br J Pharmacol. 1994 Jun;112(2):659-65.

20.

KF17837 is an A2 adenosine receptor antagonist in vivo.

Jackson EK, Herzer WA, Suzuki F.

J Pharmacol Exp Ther. 1993 Dec;267(3):1304-10.

PMID:
8263794

Supplemental Content

Support Center